Mr. Pepper said some other health systems have a combative relationship with drug manufacturers, but flipping those relations can help secure needed drugs for patients, such as cisplatin and carboplatin.
“When you have that relationship, when you’ve built that over years and you’re able to tell them, ‘I have 117 patients on cisplatin. We’re going to run out by Tuesday; we can’t get anything,’ that’s helped prove the urgency to them,” Mr. Pepper said. “It really helped us here to be able to go to these manufacturers and tell them, ‘Hey, I’ve got 66 patients on methotrexate.’ That’s what the manufacturers want.”
While being careful not to disclose personal information, Ochsner sometimes sends lists of how many patients are on a drug in shortage to speed up the approval process, too.
He recommended organizations allow some time to drugmaker representatives — such as 30 minutes twice a year since “we’re all really busy” — and going to trade shows to jump-start those relationships.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
